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Summary.-The immunogenicities of 15 murine osteosarcomata induced with a
bone seeking radioisotope (90Sr) in normal and chimaeric CBA mice were studied.
Attempts were made to induce tumour-specific immunity in syngeneic mice by
treatment with x-irradiated (15,000 rad) tumour or surgical excision of developing
subcutaneous tumour grafts. Resistance was evoked against 6 tumours and this
was relatively weak. With the remaining tumours, no resistance against the immun-
izing tumour could be demonstrated, even though the transplantation tests were
made highly sensitive by the use of inocula of as few as 2 x 103 cells in pre-irradiated
(400 rad) hosts. Sera from mice immunized against each of the tumours were tested
against viable cells of the immunizing tumour by indirect immunofluorescence.
In no instance did tumour antisera give a convincing reaction with tumour cells
although alloantisera raised by hyperimmunization of H-2 identical and H-2 different
donors with osteosarcomata consistently gave strongly positive reactions. The
results are interpreted as illustrating the weak tumour specific antigenicity of
radiation-induced murine osteosarcomata. The possibility that antigenic deficiency
is a consequence of immunosurveillance in this tumour system is discussed.
THE concept that experimentally
induced tumours may have associated
antigens (tumour specific transplantation
antigens, T.S.T.A.), against which the
host is capable of evoking an immune
response has been firmly established by
numerous investigators (Klein, 1968). In
viral oncogenesis there exists, in general,
a striking correspondence between malig-
nant transformation and the appearance
ofnewhistocompatibility antigens, specific
for the aetiologic virus. By contrast,
the situation with regard to putatively
non-viral tumours (i.e. those induced
by chemical carcinogens and physical
agents) is less clear. Not only are the
antigenic specificities different among
different tumours induced by the same
agent in the same host, but the apparent
titre of antigen varies considerably
between tumours (Sjogren, 1965). Thus,
some hydrocarbon-induced murine sarco-
mata are among the most antigenic of
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tumours whilst others appear to lack
T.S.T.A. at least in concentration suffi-
cient to provoke a significant rejection
reaction. Furthermore, certain entire
classes of tumour, such as spontaneous
mouse sarcomata (Prehn and Main, 1957),
sarcomata induced by implanted plastic
films (Klein, Sjogren and Klein, 1963)
and pulmonary neoplasms induced by
chemical carcinogens (Prehn, 1962, 1963;
Pasternak, Hoffman and Graffi, 1966)
possess little or no detectable antigenicity.
In some systems, rapidly induced
tumours are more immunogenic than
those with longer latent periods (Old
et al., 1962; Johnson, 1968), particularly
where there is a superimposed component
of immunosuppression attributable to the
carcinogen (Stjernsward, 1969). It has
been suggested that this inverse relation-
ship between antigenicity and latent
period may reflect the influence of immu-
noselection on tumour antigen expressionANTIGENICITY OF RADIATION-INDUCED MURINE OSTEOSARCOMATA
during carcinogenesis (Prehn, 1968). The
relation between these two parameters
appears, however, to be more complex
than this since murine sarcomata induced
by plastic film implantation (Klein et al.,
1963) and by u.v.-irradiation (Graffi,
Pasternak and Horn, 1964) have com-
parable latent periods, but differ signifi-
cantly in antigenic strength. A similar
lack of correlation has been demonstrated
for tumour systems in species other than
the mouse (Oettgen et al., 1968; Baldwin
et al., 1970; Baldwin and Embleton,
1971). It is thus evident that further
evaluation of the role of immune surveil-
lance on tumour antigen expression is
desirable, particularly in relation to the
site and type of tumour induced and the
nature of the carcinogenic agent.
In this paper we report on the anti-
genicity of osteosarcomata in mice arising
as a consequence of internal irradiation
with bone-seeking isotopes, by the at-
tempted induction of resistance to their
own transplantation in recipient mice,
syngeneic with the strain of origin.
These tumours, induced in normal and
chimaeric mice, possess long latency
periods (269-746 days) and in this respect
are comparable with connective tissue
tumours induced by other physical agents
(plastic film and u.v.-irradiation).
Procedures consistently effective for
demonstrating cell-mediated immunity to
a wide variety of tumour types were
employed in this study, viz. excision of
subcutaneous grafts and repeated implan-
tation of x-irradiated tumour biopsies.
Humoral immunity to tumour-specific
antigens on rodent sarcoma cells may
be demonstrated by indirect immuno-
fluorescence with serum from immunized
syngeneic donors (Baldwin et al., 1971)
and this technique has been used to
ascertain whether radiation-induced osteo-
sarcomata elicit a tumour-specific humoral
antibody response against cell-surface
expressed T.S.T.A.
MATERIALS AND METHODS
Tumours.-The induction of osteosarco-
mata by injection of 90Sr (20 uCi) in normal
and chimaeric CBA mice has been described
(Barnes et al., 1970). With one exception
(S27) primary tumours were classified histo-
logically as osteosarcomata. One tumour
in the series (Si15) was induced by a single
intraperitoneal injection of 226Ra (50 nCi).
All osteosarcomata arising in syngeneic
(CBA/CBAT6T6) and allogeneic (CBAT6T6/
A) chimaeras were confirmed to be of host
(CBA) origin by cytological and, where
appropriate, genetic analysis. Tumours were
serially passaged by subcutaneous implanta-
tion in young adult male syngeneic CBA or
CBAT6T6 mice, the genetic uniformity of
which was routinely checked by skin grafting.
TABLE I.-Primary Radiation-induced Murine Sarcomatat
Tumour Day mouse
no. killedt
S1 . 270
S5 370
S15 . 269
S16 . 375
S17 . 270
S18 . 229
S20 . 269
S27 337
S38 . 262
S39 . 342
S100 . 474
S1O0 . 411
S110 . 418
S1ll . 397
S115* . 746
Primary tumour-
bearing host
Syngeneic chimaera
Syngeneic chimaera
Allogeneic chimaera
Allogeneic chimaera
Allogeneic chimaera
Syngeneic chimaera
Syngeneic chimaera
Syngeneic chimaera
Syngeneic chimaera
Syngeneic chimaera
Normal CBA
Normal CBA
Normal CBA
Normal CBA
Normal CBA
Morphology of
primary tumour
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Fibrosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
Osteochondrosarcoma
Osteosarcoma
Osteosarcoma
Osteosarcoma
* Induced by Ra226 (50 nCi); all other tumours induced by Sr90 (20 ,uCi).
t After single injection ofradioisotope.
t By courtesy of Dr J. F. Loutit.
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Details of the tumours are presented in
Table I.
Induction of tumour immunity.-Two
procedures were used for studying the
immunogenicities of osteosarcomata passaged
in syngeneic hosts.
(i) Implantation of irradiated tumour.-
Tumour implants (approximately 4 mm x
4 mm) suspended in tissue culture medium
199, were exposed to x-irradiation from a
Westinghouse x-ray therapy unit operating
at 220 kV and 14 mA with 1 mm Cu and
1 mm Al filtration (half value layer 1 82 mm
Cu). They were inactivated by 15,000 rad
delivered at the rate of 375 rad/min.
Irradiated pieces were then immediately
implanted subcutaneously under the dorsal
skin. Where practicable, bilateral implants
were preferred to unilateral implants so as
to stimulate a larger mass of recipient
lymphoid tissue.
The immunization schedule usually con-
sisted of a minimum of three implantations
of irradiated tissue at intervals of 10 to 21
days depending on the growth rate of the
respective viable tumours. Control mice
were similarly treated with irradiated normal
tissues (kidney, liver, muscle and spleen).
In some tests additional controls included
mice with grafted irradiated tumour from
transplanted soft tissue sarcomata of recent
origin in CBA mice, induced by 3-methyl-
cholanthrene and F.B.J. murine osteosarcoma
virus (Finkel, Biskis and Jinkins, 1966;
Price, Moore and Jones, 1972). The former
were characterized by individually distinctive
T.S.T.A. while the latter possessed T.S.T.A.
common to sarcomata induced by F.B.J.
virus (to be published).
(ii) Excision of subcutaneous tumour.-
Subcutanequsly developing tumour grafts
were surgically excised, complete with over-
lying skin, when they attained an average
diameter of 8-10 mm.
Tumour challenge.-Challenge inocula of
defined numbers of tumour cells were given
7 to 14 days after the last irradiated graft, or
following tumour excision.
For this purpose, tumour was prepared
as a single cell suspension by dissociation
in 0 250% trypsin (Difco, 1: 250) in Hanks'
balanced salt solution. After washing by
centrifugation and suspension in M199, cells
were assessed for viability by trypan blue
exclusion. Preparations ofexceptionally low
viability (<250%) or which were prone to
cell clumping were not used for tumour
challenge.
In each test a group of untreated control
mice was included and all animals received
total body x-irradiation (400 rad delivered at
the rate of 33-5 rad/min) 24 hours prior to
inoculation. This treatment suppresses any
primary immune response to the tumour
inoculum in the course of early latency
without markedly affecting the secondary
response in previously immunized mice
thereby allowing weak levels of tumour
resistance to be detected.
In preliminary tests it was necessary to
establish the number of cells of each tumour
required to sustain progressive growth in at
least 50% of pre-irradiated (400 rad) but
otherwise untreated recipients. These thres-
hold cell numbers varied appreciably from
tumour to tumour. The first tumour chal-
lenge was then usually given at a dose
comparable to the threshold inoculum.
Thereafter mice were examined twice weekly
and tumour sizes were taken as the mean of
two diameters.
Sera.-Sera were obtained from mice
immunized with individual osteosarcomata
by multiple implantation of irradiated
tumour. Mice were bled under ether anaes-
thesia from the retro-orbital plexus, 7 to
10 days after the last irradiated graft. Sera
were stored at -20°C until required.
Alloantisera were raised in H-2 different
(A strain), and H-2 identical (C3H strain)
mice, by hyper-immunization with viable
grafts of CBA osteosarcomata.
Immunof aorescence.-Sera were tested for
anti-tumour antibodies by the indirect
fluorescent antibody test, as modified by
Moller (1961), for use with suspensions of
viable cells.
Suspensions of viable tumour cells were
prepared as described by trypsinization of
fresh tumour tissue from mice bearing
osteosarcoma transplants. Cells were washed
free of enzyme, resuspended in medium 199
and distributed in tubes (5 x 106 cells per
tube). After centrifugation, the cells were
resuspended in 0-1 ml of undiluted test or
control serum and incubated at 37°C with
gentle agitation for 20 min. Cells were then
washed three times in culture medium and
resuspended in 0-1 ml fluorescein-conjugated
globulin fraction of unabsorbed horse anti-
mouse globulin (dilution 1/10) (Progressive
Laboratories, Baltimore, Maryland, U.S.A.).
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This reagent gave a strong single IgG line
on immunoelectrophoresis with mouse serum.
After incubation for 20 min at room tem-
perature the cells were washed three times,
suspended finally in 01-42 ml 50%1 glycerol
in saline and examined under a coverslip
with u.v. and fluorescence microscopy using
a dark ground condenser with toric lens
beneath, and a colourless barrier filter. The
presence of antibody was indicated by
various degrees of fluorescence at the cell
membrane ranging from reactions in which
a virtually complete surrounding ring was
visible, to lesser reactions in which isolated
sectors of brighter fluorescence appeared at
the cell membrane. In every test, negative
controls (sera from normal CBA mice) were
included in addition to positive controls
(alloantisera from A and C3H strain mice
immunized with radiation induced osteo-
sarcomata). In no instance was non-specific
staining of tumour cells observed.
Fluorescence indices (FI) were calculated
as the proportion of unstained cells in the
sample exposed to control mouse serum
minus the proportion of unstained cells in
the sample exposed to the test serum,
divided by the former figure. An index of
0 3 or greater was considered, on statistical
grounds, to represent a significant reaction.
RESULTS
Response to irradiated tumour isografts
Fifteen radiation-induced sarcomata
were examined for their capacity to
induce resistance to their own trans-
plantation in syngeneic CBA mice, by
prior treatment with irradiated tumour
cells.
Of these, 6 tumours (S15, S17, S20,
S38, S100 and S115) were immunogenic
in that the number of tumour takes in
TABLE II.-Immune Response to Irradiated Grafts of Radiation-induced
Murine Sarcomata
Tumour outgrowth in
, K A~~~~~~
Treated Latent Untreated Latent
mice periodt controls period
9/9 23 8/8 17
4/6 0 2/5 30
7/7 7 7/7 7
0/6 3/5 19
7/8 16 6/6 9
8/9 23 5/5 23
6/6 34 4/6 34
4/7 37 4/5 29
10/11 36 5/6 29
6/6 18 4/5 18
4/8 35 4/5 22
8/8 24 6/6 24
6/6 19 5/6 19
0/8 4/6 29
5/5 29 6/6 36
7/8 29 6/6 36
5/10 36 3/6 36
0/8 2/6 20
9/10 14 6/6 14
4/7 74 2/4 53
7/7 53 4/4 38
9/9 31 6/6 31
4/5 14 4/5 14
7/7 12 4/6 12
7/7 21 6/6 21
4/5 20 5/5 13
4/6 24 5/5 17
5/6 24 6/6 16
4/8 22 6/6 17
3/10 22 4/6 17
* Mice received 400 rad whole-body x-irradiation 24 hours prior to challenge.
t Time in days at which tumours were first palpable.
Immunizing
tumour and
transplant
generations
S1/3-5
S5/11-12
S5/26-28
S15/14-23
S15/35-36
S16/15-17
S16/18-19
S17/9-15
S17/18-19
S18/16-25
S20/17-18
S20/24-26
S27/17-19
S38/10-11
S39/11-18
S39/14-18
S39/24-27
S100/3-6
S100/14-15
S101/7-16
S101/13-16
S101/17-18
8110/8-9
81O/12-13
811/10-12
S115/5-6
S115/5-6
S115/2-3
S115/8-9
S115/8-9
No. of
irradiated
grafts
4
5
4
8
3
3
3
8
4
8
3
3
4
3
8
4
4
5
3
12
4
4
3
3
4
4
4
4
3
3
Challenge
tumour
transplant
generation
S1/7
S5/13
S5/29
S15/24
S15/37
S16/17
S16/18
S17/16
S17/18
S18/25
S20/18
S20/26
S27/20
S38/11
S39/18
S39/18
S39/27
S100/7
S100/16
S101/16
S101/16
S101/19
S l10/8
S110/12
S111/12
S115/7
S115/7
S115/4
S115/10
S115/10
Cell
dose*
5 x104
2 x 103
5x 104
5X 103
1 X 104
1 X 104
2X 103
2X 103
2X 103
2X 103
1 X 104
2X 104
1 X 104
5X 103
1 X 104
1 X 104
5 103
2X 103
5X 103
1 X 104
5X 104
2X 104
2 x 103
5X 103
5X 103
2X 103
1 X 103
5X 103
I X 103
5 X102
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DAYS POST CHALLENGE
FIG. 1.-Growth of radiation-induced osteo-
sarcoma 8115 (103 cells) in normal syn-
geneic mice ( 0), mice pretreated
repeatedly with irradiated (15,000 rad)
grafts of osteosarcoma S115 (0 O),
and a chemically induced sarcoma
(A- A); and following surgical excision
of osteosarcoma S115 (* ).
immunized hosts was reduced compared
with those in normal untreated mice
(Table II, Fig. 1 and 2). Furthermore,
in certain additional examples, the rate
of tumour outgrowth in immunized hosts
compared with controls was significantly
retarded. Thus, in some mice immunized
DAYS POST CHALLENGE
FIG. 2. Growth of radiation-induced osteo-
sarcoma S20 (104 cells) in normal syn-
geneic mice ( 0), mice pretreated
repeatedly with irradiated grafts of osteo-
sarcoma S20 (0 O), and a chemically
induced sarcoma (A- A); and following
surgical excision of osteosarcoma 820
(- *)-
and challenged with S101, tumour out-
growth was suppressed for periods up to
150 days although ultimate protection
was not achieved. In no example studied
did the level of immunity evoked in
immunized mice exceed the threshold
inoculum for pre-irradiated (400 rad)
TABLE III.-Specificity of Resistance Induced by Radiation-induced Murine
Immunizing
tissue
S15/14-23
Normal
S17/9-15
Normal
MC-1/3-5
S20/17-18
MC-2/5-6
S38/10-11
Normal
S115/16-18
S115/8-9
MC-1/3-5
FBJ7/5-8
No. of
irradiated
grafts
8
8
8
8
4
Challenge
tumour and
transfer
generation
815/24
. 15/24
. 17/16
. 17/16
S17/22
Osteosarcom
Cell
dose*
* 5x103
* 5x103
tata
Tumour outgrowth in
Treated Latent Untreated Latent
mice periodt controls period
0/6 -19 6/6 19 f 66 1
2x 103 . 4/7
2 2x103 . 5/5
2x 103 . 3/4
37
29
29 }
3 . S20/18 . 1 x 104 . 4/8 35
4 . S20/18 . 1x 04 * 9/9 22 f
3 . S38/11 . 5x 103 . 0/8 -
3 . S38/11 5x 103 . 6/6 29
5
4
4
4
* FBJ6/6
S115/10
S115/10
. S115/14 .
5x 103
IX 103
IX 103
IX 103
9/9
4/8
10/10
9/9
27
22
17
17
4/5
6/6
29
30
6/6 22
4/6
6/6
} 6/6
7/8
29
27
17
17
MC = Sarcomata induced originally by 3-methylcholanthrene.
FBJ = Sarcomata induced originally with FBJ murine sarcoma virus.
* Mice received 400 rad whole-body x-irradiation 24 hours prior to challenge.
t Time in days at which tumours were first palpable.
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non-immunized controls by one logarith-
mic unit, indicating that the degree
of resistance induced to the osteosarco-
mata was of a relatively low order.
The remaining 9 sarcomata in the
series revealed only a very slight immuno-
genicity which was not always repro-
ducible, or were found to be completely
inactive by this transplantation-immuni-
zation procedure.
To establish that the observed
antigenicity of the radiation-induced
sarcomata was not attributable to a
non-specific increase in immunological
responsiveness, mice variously received
irradiated grafts of normal tissues, or
chemically induced or virally induced sar-
comata of soft tissue origin in CBA mice
known from comparable transplantation
tests to possess T.S.T.A.s. Thereafter they
were challenged with those osteosarco-
mata which had earlier revealed anti-
genicity. Such pretreatment failed to
protect against low tumour cell inocula
confirming the association of weak
T.S.T.A. with the osteosarcomata (Table
III, Fig. 1 and 2).
Of the weakly immunogenic tumours,
the primaries of 4 (S38, S15, S20 and
S17) arose in chimaeric mice and in
general appeared earlier than the non-
immunogenic tumours (Table I). Two
weakly immunogenic tumours (S100 and
S115) appeared in normal mice, of which
one (S115) was induced by 226Ra with a
very long latent period (746 days).
In two examples (S16 and S1io), tumour
outgrowth appeared to be facilitated in
mice pretreated with irradiated tumour
biopsies compared with untreated con-
trols.
Response to tumour excision
The immunogenicity of 9 sarcomata
was examined following surgical removal
and challenge with the same tumour.
Evidence of weak transplantation resist-
ance was obtained in only one instance
(S20) following excision of subcutaneous
grafts (Table IV). In this case, tumour
outgrowth from a challenge of 104 cells
was not detectable until 13 days after
that in controls, and 4/8 immunized
mice remained resistant compared with
5/6 non-immunized controls which grew
tumours (Fig. 2). Surgical removal also
delayed the appearance of challenge
tumour cells in mice which had borne
grafts of S17 but in this example no
complete protection ensued. In both
cases, once tumours had developed they
grew at comparable rates in test and
control groups.
The remaining 7 sarcomata evoked
neither resistance nor enhancement fol-
lowing tumour excision.
TABLE IV.-Immune Response Following Excision ofSubcutaneous Grafts of
Radiation-induced Murine Sarcomata
Immunizing Challenge Tumour outgrowth in
Treated
mice
5/6
4/7
6/7
5/5
4/8
8/9
5/5
8/9
5/5
5/5
6/6
Latent Untreated
periodt controls
13 5/5
34 4/6
37 5/6
19 5/5
37 5/6
25 5/6
42 5/6
25 5/6
14 4/5
17 6/6
17 4/6
Latent
period
13
34
37
19
24
25
42
25
14
17
17
* Mice received 400 rad whole-body x-irradiation 24 hours prior to challenge.
t Time in days at which tumours were first palpable.
tumour and
transfer
generation
S15/24
S16/18
S17/17
S18/16
S20/19
S38/22
S39/24
S101/20
S110/12
S115/9
S115/9
tumour and
transfer
generation
S15/25
S16/18
S17/18
S18/16
S20/19
S38/22
S39/25
S101/20
S110/8
S115/10
S115/10
Cell
dose*
5x 103
2 x 103
2 x103
5x 103
1 x 104
2x 104
5x 103
2x 104
2x 103
1 X 103
5x 102
I
I
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Immunoftuorescence studies
Tests were carried out with sera
from mice immunized against each of
the radiation sarcomata by multiple
implantation of irradiated tumour grafts.
In no instance was a convincing mem-
brane immunofluorescence reaction
demonstrable following incubation with
cells of the immunizing tumour or of any
of the other radiation sarcomata, the
fluorescence indices varying from 0 to
0*22.
By contrast, alloantisera from 11-2
identical and H-2 different donors hyper-
immunized against osteosarcomata reacted
consistently with cell-surface expressed
alloantigens on the osteosarcoma cells
with fluorescence indices in the range
0 33 to 100.
DISCUSSION
The presence of tumour specific trans-
plantation antigens (T.S.T.A.) defined by
their capacity to elicit rejection responses
in syngeneic hosts, has been demon-
strated in many experimentally induced
neoplasms (Klein, 1968).
The principal finding of this investiga-
tion was that radiation induced murine
osteosarcomata constitute a class of
weakly or non - immunogenic tumours
as determined by transplantation tests.
Thus, in only 6/15 tumours tested could
resistance be induced by pretreatment
with irradiated (15,000 rad) tumour grafts
and this was relatively weak as measured
by the maximum cell inoculum rejected
by immunized hosts (1 x 104 cells).
Resistance following excision of progres-
sively growing tumour was demonstrated
in one instance only. Since both these
immunization procedures are consistently
effective for inducing resistance to a
variety of antigenic tumour types, we
conclude that the immunogenicity of
radiation induced murine osteosaromata
is of a relatively low order.
The absence of strong antigenicity
among these tumours was further emphas-
ized by the failure to detect cell surface
antigens by indirect immunofluorescence
with sera from specifically immunized
syngeneic donors. This technique has
been widely applied to the detection of
T.S.T.A.s of different tumour types and
in general there exists a correlation
between host resistance and the presence
of tumour specific humoral antibody
(Baldwin et al., 1971). The validity of
the indirect fluorescent antibody test
for detecting membrane associated anti-
gens of murine osteosarcoma cells was
confirmed by highly reproducible reactions
obtained with alloantisera from H-2
identical and H-2 different mice.
These experiments imply that most
murine radiation-induced osteosarcomata
have a paucity of tumour-specific cell
surface antigens. However, it is known
that tumour antigen expression at the
cell membrane may be modified by
enhancing antibody (Hellstrom et al.,
1969) and/or other masking mechanisms
(Currie and Bagshawe, 1969), as well as
by serial passage through immunocom-
petent hosts (Woodruff and Symes, 1962;
Prehn, 1967). Thus, antigenic deficiency
in this tumour system may be a quantita-
tive rather than a qualitative pheno-
menon. In this context, it is of interest
that transplantation resistance appeared
to be evoked more readily against osteo-
sarcomata in " early " passage rather
than " late " (see Table II with reference
to osteosarcomata S15, S17, S20 and
8100), suggesting possible deletion of
tumour antigens on repeated transplanta-
tion within the strain oforigin. However,
since the tumour challenge inocula were,
with the exception of S17, not identical
for mice immunized against " early " and
" late " transplants of these tumours
this conclusion is not justified. Further-
more, throughout the investigation, there
were no noteworthy changes in the
behavioural characteristics of the osteo-
sarcomata with respect to growth rate or
ability to metastasize which were sug-
gestive of a significant alteration in
host-tumour relationship.
It may also be argued that the tumours
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carry T.S.T.A.s but that the hosts are
unresponsive to them. Such an argu-
ment might receive some support if, as
as has been postulated (Finkel and Biskis,
1968), a latent viral entity is activated in
radiation oncogenesis in the mouse. In
this respect, determination of the anti-
genic-specificity of the induced tumour
resistance would be potentially indicative.
However, on account ofthe weak immuno-
genicities of the radiation-induced sarco-
mata, antigen cross-reactivity studies have
not so far yielded definitive information
on this question. It would appear more
likely, however, that T.S.T.A.s in radia-
tion-induced sarcomata arise as a result
of radiation exposure during adult life.
Hence, any immune unresponsiveness
would be evoked as a result of weak
antigenic stimulation and not as a conse-
quence of neonatal exposure to antigen.
The radiation-osteosarcomata consid-
ered as a group contrast with connective
tissue sarcomata induced by chemical
carcinogens, which are in general, though
not invariably, strongly immunogenic
(Baldwin, 1970) and with sarcomata
induced by u.v.-radiation which are
moderately immunogenic (Graffi et al.,
1964). However, the property of weak
autigenicity is shared by soft tissue
sarcomata induced in mice by the sub-
cutaneous implantation of plastic and
cellophane films (Klein et al., 1963) as
well as those spontaneous mesenchymal
sarcomata where the aetiology is unknown
(Prehn and Main, 1957).
The emergence of strongly antigenic
tumours induced by chemicals is thought
to be facilitated, at least in some circum-
stances, by the immunosuppressive acti-
vity of the carcinogenic agent (Stjerns-
ward, 1.965, 1966). In comparable studies
the same author (Stjernsward, 1969)
has reported that mice given oncogenic
dosages of 90Sr are immunodepressed for
7 months, i.e. until the time of the
appearance of the first osteosarcomata.
In contrast to chemically induced sarco-
mata, in this investigation no strongly
antigenic tumours were encountered even
8
in radiation chimaeras, which are immuno-
logically hyporesponsive (Micklem and
Loutit, 1966).
The phenomenon of weak antigenicity
of radiation-induced murine osteosarco-
mata could be explained in terms of
immunoselection, if bone proved to be
an unusually efficient site for the mani-
festation of immunity, i.e. an immuno-
logically " under-privileged " site. Prehn
(1968) suggested such might be the case
for the lung in respect of failures to
demonstrate significant antigenicity
among chemically induced pulmonary
tumours. However, the absence of a
significant lymphocytic reaction around
early osteosarcomata (Loutit, personal
communication) does not support this
view unless it is postulated that immuno-
selection takes place at such an early
stage in bone tumourigenesis that even
the smallest osteosarcomata are of non-
antigenic type. Moreover, this theory
appears to be contra-indicated by studies
on the comparative antigenicity of osteo-
sarcomata in rats. Transplantation tests
in progress indicate that osteosarcomata
induced by a chemical carcinogen differ
significantly in antigenic strength from
those induced by irradiation (phosphorous-
32), suggesting that in these contrasting
models of bone oncogenesis, antigenicity
is more a function of the carcinogenic
agent than the site of tumour origin (to
be published).
The interpretation of the weak anti-
genicity ofradiation-induced murine osteo-
sarcomata simply in terms of immuno-
surveillance is limited by a number of
contrary observations, viz. the fact that
in some systems antigenic tumours may
emerge after long latent periods during
which selection against antigenic variants
might be expected to operate; and that
relatively non-antigenic tumours occur
in immunologically deficient hosts and
thus are not a direct consequence of an
immune reaction. This latter pheno-
menon has been strikingly demonstrated
in recent work with in vitro carcinogenesis
where some transformed cell lines trans-
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ferred to hosts of the genotype of origin
were highly antigenic, whereas others
had little or no detectable antigenicity
(Prehn, 1970).
We are indebted to Dr J. F. Loutit,
MRC Radiobiology Unit, Harwell, Berk-
shire, for initially providing the tumours
for this investigation and for criticism
of this manuscript.
We also thank Mr N. W. Nisbet,
Director of Research, for his encourage-
ment, and Mrs Meriel Jackson for secre-
tarial assistance.
This project was supported by grants
from the Cancer Research Campaign and
the Medical Research Council.
REFERENCES
BALDWIN, R. W. (1970) Tumor Specific Antigens
Associated with Chemically Induced Tumours.
Rev. Etud. clin. biol. 15, 1.
BALDWIN, R. W. & EMBLETON, M. J. (1971) Tumor-
specific Antigens in 2-acetylaminofluorene-induced
Rat Hepatomas and Related Tumours. I8rael
J. med. Sci., 7, 144.
BALDWIN, R. W., BARKER, C. R., EMBLETON, M. J.,
GLAVES, D., MOORE, M. & PIMM, M. V. (1971)
Demonstration of Cell-surface Antigens on
Chemically Induced Tumours. Ann. N.Y. Acad.
Sci., 177, 268.
BALDWIN, R. W., BARKER, C. R., EMBLETON,
M. J. & MOORE, M. (1970) Immunology of
Carcinogen-induced Rat Hepatomas and Mam-
mary Adenocarcinomas. In Immunity and Toler-
ance in Oncogenesis (Proc. IV Perugia Quadrennial
Int. Conf. on Cancer, Vol. 1). Ed. L. Severi.
Perugia University. p. 11.
BARNES, D. W. H., CARR, T. E. F., EVANS, E. P.
& LOUTIT, J. F. (1970) 90Sr-induced Osteosar-
comas in Radiation Chimaeras. Int. J. Radiat.
Biol., 18, 536.
CURRIE, G. A. & BAGSHAWE, K. D. (1969) Tumour
Specific Immunogenicity of Methylcholanthrene-
induced Sarcoma Cells after Incubation in
Neuraminidase. Br. J. Cancer, 23, 141.
FINXEL, M. P. & BISKIS, B. 0. (1968) Experimental
Induction of Osteosarcomas. Prog. exp. Tumor
Res. 10, 72.
FINKEL, M. P., BISKIS, B. O. & JINKINS, P. B.
(1966) Virus Induction of Osteosarcomas in
Mice. Science, N.Y., 151, 698.
GRAFFI, A., PASTERNAK, G. & HORN, K. H. (1964)
Die Erzengung von Resistenz gegen isologe
Transplantate UV-induzierter Sarkome der Maus.
Acta biol. med. germ., 12, 726.
HELLSTROM, I., HELLSTR6M, K. E., EVANS, C. A.,
HEPPNER, G. H., PIERCE, G. E. & YANG, J. P. S.
(1969) Serum-mediated Protection of Neoplastic
Cells from Inhibition by Lymphocytes Immune
to their Tumour Specific Antigens. Proc. natn.
Acad. Sci. U.S.A., 62, 362.
JOHNSON, S. (1968) The Effect of Thymectomy and
of the Dose of 3-methylcholanthrene on the
Induction and Antigenic Properties of Sarcomas
in C57B1 Mice. Br. J. Cancer, 22, 93.
KLEIN, G. (1968) Tumor-specific Transplantation
Antigens. Cancer Res., 28, 625.
KLEIN, G., SJOGREN, H. 0. & KLEIN, E. (1963)
Demonstration of Host Resistance against Sar-
comas Induced by Implantation of Cellophane
Films in Isologous (Syngeneic) Recipients. Cancer
Res., 23, 84.
MICKLEM, H. S. & LOUTIT, J. F. (1966) Immuno-
logical Reactivity of the Radiation Chimera.
In Tissue Grafting and Radiation. New York:
Academic Press. Chap 5, p. 119.
MOLLER, G. (1961) Demonstration of Mouse Iso-
antigens at the Cellular Level by the Fluorescent
Antibody Technique. J. exp. Med., 114, 415.
OETTGEN, H. F., OLD, L. J., McLEAN, E. P. &
CARSWELL, E. A. (1968) Delayed Hypersensitivity
and Transplantation Immunity Elicited by
Soluble Antigens of Chemically Induced Tumours
in Inbred Guinea-pigs. Nature, Lond., 220, 295.
OLD, L. J., BoYsE, E. A., CLARKE, D. A. & CARS-
WELL, E. A. (1962) Antigenic Properties of
Chemically Induced Tumors. Ann. N.Y. Acad.
Sci., 101, 80.
PASTERNAK, G., HOFFMAN, F. & GRAFFI, A. (1966)
Growth of Diethylnitrosamine-induced Lung
Tumors in Syngeneic Mice Specifically Pretreated
with x-ray Killed Tumor Tissue. Folia biol.,
12, 299.
PREHN, R. T. (1962) Specific Isoantigenicities
among Chemically-induced Tumours. Ann. N. Y.
Acad. Sci., 101, 107.
PREHN, R. T. (1963) Tumor Specific Immunity to
Nonviral Tumors. Can. Cancer Conf., 5, 387.
PREHN, R. T. (1967) The Significance of Tumor-
Distinctive Histocompatibility Antigens. In Cross-
reacting Antigens and Neoantigens, Ed. John J.
Trentin. Baltimore: Williams & Wilkins. p.
105.
PREHN, R. T. (1968) Tumor-specific Antigens of
Putatively Nonviral Tumors. Cancer Res., 28,
1326.
PREHN, R. T. (1970) In Immune Surveillance.
Ed. R. T. Smith and M. Landy. London:
Academic Press. p. 454.
PREHN, R. T. & MAIN, J. M. (1957) Immunity to
Methylcholanthrene-induced Sarcomas. J. natn.
Cancer Inst., 18, 769.
PRICE, C. H. G., MOORE, M. & JoNEs, D. B. (1972)
FBJ Virus-induced Tumours in Mice. Br. J.
Cancer, 26, 15.
SJ6GREN, H. 0. (1965) Transplantation Methods
as a Tool for Detection ofTumor-specific Antigens.
Prog. exp. Tumor Res., 6, 289.
STJERNSWARD, J. (1965) Immunodepressive Effect
of 3-methylcholanthrene. Antibody Formation
at the Cellular Level and Reaction Against
Weak Antigenic Homografts. J. natn. Cancer
Inst., 35, 885.
STJERNSWXRD, J. (1966). Effect ofNoncarcinogenic
and Carcinogenic Hydrocarbons on Antibody-
forming Cells Measured at the Cellular Level
in vitro. J. natn. Cancer Inst. 36, 1189.
STJERNSWARD, J. (1969) Immunosuppression by
Carcinogens. Antibiotica Chemother., 15, 213.
WOODRUFF, M. F. A. & SYMEs, M. 0. (1962) Evi-
dence of Loss of Tumour Specific Antigen on
Repeatedly Transplanting a Tumour in the
Strain of Origin. Br. J. Cancer, 16, 484.